Prosecution Insights
Last updated: May 29, 2026

Research Development Foundation

10 pending office actions • 9 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days

Portfolio Summary

10
Total Pending OAs
6
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

9
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (9)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
5
Medium (50%)
3
Easy (30%)
2
Unknown (20%)

Rejection Statute Mix

BucketCases
§103 only5 (50%)
§112 only2 (20%)
Double-patenting only1 (10%)
No statute on record2 (20%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

8
Life Sciences
80% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
20% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

100 h
Manual time on pending OAs
20 h
Time saved (low, 20%)
35 h
Time saved (mid, 35%)
0.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PAGUIO FRISING, MICHELLE F 1 70.5% +40.7%
BUTTICE, AUDREY L 1 45.8% +21.5%
BEHARRY, ZANNA MARIA 1 23.3% +54.0%
FAN, LYNN Y 1 46.6% +49.1%
NOBLE, MARCIA STEPHENS 1 67.0% +40.2%
OGUNBIYI, OLUWATOSIN A 1 63.3% +42.1%
LI, RUIXIANG 1 59.4% +19.0%
DESAI, ANAND U 1 78.9% +12.2%
ANJARIA, SHREYA PARAG 1 52.8% +29.1%
HUH, VYNN V 1 61.9% +44.9%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18248739 METHODS FOR MAKING AND USING DIFFERENTIATED NEURAL CELLS BEHARRY, ZANNA MARIA 19d overdue

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17548467 SYSTEMS AND METHODS FOR LASER-INDUCED CALCIUM FRACTURES ANJARIA, SHREYA PARAG 134d overdue
18060134 METHODS AND PROBIOTIC COMPOSITIONS FOR THE TREATMENT OF BONE DISORDERS FAN, LYNN Y 79d overdue
18052476 SERINE PROTEASE MOLECULES AND THERAPIES LI, RUIXIANG 77d overdue
17346563 SYSTEMS AND METHODS FOR IMAGING AND MANIPULATING TISSUE HUH, VYNN V 45d overdue
17998194 PROTEINS AND NUCLEIC ACIDS FOR EHRLICHIA DIAGNOSIS AND VACCINATION OGUNBIYI, OLUWATOSIN A 36d overdue
18332571 ENGINEERED FCRIIB SELECTIVE IGG1 FC VARIANTS AND USES THEREOF BUTTICE, AUDREY L 28d overdue
17567868 METHODS FOR PREDICTING KINASE INHIBITOR RESISTANCE DESAI, ANAND U 24d overdue
18248739 METHODS FOR MAKING AND USING DIFFERENTIATED NEURAL CELLS BEHARRY, ZANNA MARIA 19d overdue

Top Art Units

Art UnitApps
1632 2
1651 1
1647 1
1759 1
1645 1
1674 1
1655 1
3796 1
3792 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18413541 METHODS AND PROBIOTIC COMPOSITIONS FOR THE TREATMENT OF METABOLIC DISEASES AND DISORDERS PAGUIO FRISING, MICHELLE F 1651 DP Non-Final OA 84d Pending Jan 16, 2024
18332571 ENGINEERED FCRIIB SELECTIVE IGG1 FC VARIANTS AND USES THEREOF BUTTICE, AUDREY L 1647 §103 Non-Final OA 28d overdue Pending Jun 09, 2023
18248739 METHODS FOR MAKING AND USING DIFFERENTIATED NEURAL CELLS BEHARRY, ZANNA MARIA 1632 Other Non-Final OA 19d overdue Pending Apr 12, 2023
18060134 METHODS AND PROBIOTIC COMPOSITIONS FOR THE TREATMENT OF BONE DISORDERS FAN, LYNN Y 1759 §103 Final Rejection 79d overdue Pending Nov 30, 2022
18060183 ELIMINATION OF PROLIFERATING CELLS FROM STEM CELL-DERIVED GRAFTS NOBLE, MARCIA STEPHENS 1632 §112 Non-Final OA 17d overdue Pending Nov 30, 2022
17998194 PROTEINS AND NUCLEIC ACIDS FOR EHRLICHIA DIAGNOSIS AND VACCINATION OGUNBIYI, OLUWATOSIN A 1645 Other Non-Final OA 36d overdue Pending Nov 08, 2022
18052476 SERINE PROTEASE MOLECULES AND THERAPIES LI, RUIXIANG 1674 §112 Final Rejection 77d overdue Pending Nov 03, 2022
17567868 METHODS FOR PREDICTING KINASE INHIBITOR RESISTANCE DESAI, ANAND U 1655 §103 Final Rejection 24d overdue Pending Jan 03, 2022
17548467 SYSTEMS AND METHODS FOR LASER-INDUCED CALCIUM FRACTURES ANJARIA, SHREYA PARAG 3796 §103 Final Rejection 134d overdue Pending Dec 10, 2021
17346563 SYSTEMS AND METHODS FOR IMAGING AND MANIPULATING TISSUE HUH, VYNN V 3792 §103 Non-Final OA 45d overdue Pending Jun 14, 2021

Managing Research Development Foundation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month